MAGNYL 1000 (USA Domestic) Magnus Magnus Pharmaceuticals: Compound Profile
MAGNYL 1000 is a human chorionic gonadotropin preparation developed by Magnus Pharmaceuticals for in-vitro laboratory investigations. This glycoprotein hormone compound consists of alpha and beta subunits and serves as a valuable research tool for scientists studying reproductive endocrinology, luteinizing hormone receptor binding mechanisms, and steroidogenesis pathways. Researchers investigating post-cycle therapy protocols and gonadotropin-mediated cellular responses utilise this compound to examine hormone-receptor interactions in controlled laboratory environments. The preparation provides researchers with access to pharmaceutical-grade hCG for comprehensive endocrine system studies.
Laboratory Applications
Research teams at Stroid UK Shop employ MAGNYL 1000 to investigate luteinizing hormone receptor activation, Leydig cell steroidogenesis, and reproductive hormone cascade mechanisms. Scientists studying post cycle therapy compounds analyse this preparation alongside other research chemicals to understand hormonal recovery patterns. Laboratory investigations focus on receptor binding kinetics, intracellular signalling pathways, and steroidogenic enzyme activation. Researchers examining endocrine disruption and hormonal restoration mechanisms incorporate this compound into comprehensive study protocols. Comparative studies with selective androgen receptor modulators and peptide research compounds provide insights into hormone axis interactions.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Human Chorionic Gonadotropin |
| Strength | 1000 IU per vial |
| Manufacturer | Magnus Pharmaceuticals |
| Form | Lyophilised powder |
| Storage | 2-8°C refrigerated |
| Reconstitution | Bacteriostatic water required |
| CAS Number | 9002-61-3 |
| Molecular Weight | Approximately 38,000 Da |
Research Compliance
MAGNYL 1000 is manufactured exclusively for laboratory research applications and in-vitro scientific studies. This product requires proper laboratory handling procedures, appropriate storage conditions, and qualified research personnel. All investigations must comply with institutional research protocols and applicable regulations governing research chemical usage. This compound is not approved for human consumption, therapeutic applications, or any purpose outside controlled laboratory research environments.
